RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

NACompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

October 20, 2021

Study Completion Date

November 2, 2021

Conditions
Embolic Stroke of Undetermined SourceTransient Ischemic AttackRight-To-Left Atrial ShuntPatent Foramen Ovale
Interventions
DIAGNOSTIC_TEST

NeuralBot Investigational System

The NeuralBot Investigational System when used with the Lucid M1 System is a medical ultrasound device which assists the user in the setup and acquisition of cerebral blood flow velocity via the patient's temporal windows. It is intended for use as an adjunct to standard clinical practices for measuring and displaying cerebral blood flow velocity and the occurrence of transient emboli within the blood stream.

DIAGNOSTIC_TEST

Transthoracic Echocardiography (TTE)

A test that uses ultrasound to create a hemodynamic assessment for major cardiovascular events.

Trial Locations (7)

37404

CHI Memorial Hospital, Chattanooga

38163

The University of Tennessee Health Science Center, Memphis

77030

Houston Methodist Neurological Institute, Houston

85013

Barrow Neurological Institute, Phoenix

97225

Providence Brain & Spine Institute, Portland

Providence St. Vincent Medical Center, Portland

98122

Swedish Hospital, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NovaSignal Corp.

INDUSTRY

NCT04604015 - RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt | Biotech Hunter | Biotech Hunter